MESO vs UTHR
Mesoblast Limited · United Therapeutics Corporation
Relative return (rebased to 100)
Key stats
| Metric | MESO | UTHR |
|---|---|---|
| Price | $14.27 | $550.10 |
| Market Cap | $18.51B | $23.59B |
| P/E | — | 17.68 |
| P/B | 32.20 | 3.69 |
| P/S | 1076.07 | 7.41 |
| ROE | -17.8% | 20.9% |
| Net Margin | -593.9% | 41.9% |
| Gross Margin | — | 87.9% |
| Revenue Growth | 191.4% | 10.6% |
| Dividend Yield | — | — |
| EPS | -$0.08 | $31.12 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.